Aberrant Expression of MicroRNAs in B-cell Lymphomas
Journal:
MicroRNA
Volume:
5
Page:
87-105
Author(s):
Carla Sole, Erika Larrea, Lorea Manterola, Ibai Goicoechea, María Armesto, María Arestin, María M. Caffarel, Angela M. Araujo, Marta Fernandez-Mercado, María Araiz and Charles H. Lawrie
Formulation and Evaluation of Rifampicin Liposomes for Buccal Drug Delivery
Journal:
Current Drug Delivery
Volume:
13
Page:
1084-1099
Author(s):
Srinivas Lankalapalli and V. S. Vinai Kumar Tenneti
Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Journal:
Current Nanomedicine
Volume:
6
Page:
78-104
Author(s):
Rajendra Awasthi, Isha Pant, Giriraj T Kulkarni, Irene Satiko Kikuchi, Terezinha de Jesus Andreoli Pinto, Kamal Dua and Venkata Ramana Malipeddi
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Journal:
Clinical Cancer Drugs
Volume:
3
Page:
76-86
Author(s):
Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter
The Many Faces of MTA3 Protein in Normal Development and Cancers
Journal:
Current Protein & Peptide Science
Volume:
17
Page:
726-734
Author(s):
Lang Ma, Zhimeng Yao, Weilun Deng, Dianzheng Zhang and Hao Zhang
Therapeutic Immunoconjugates. Which Cytotoxic Payload: Chemotherapeutic Drug (ADC) or Radionuclide (ARC) ?
Journal:
Current Cancer Therapy Reviews
Volume:
12
Page:
54-65
Author(s):
Jean-François Chatal, Françoise Kraeber-Bodéré, Caroline Bodet-Milin and Caroline Rousseau
PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Journal:
Current Drug Targets
Volume:
17
Page:
1661-1672
Author(s):
Julia Alejandra Pezuk, Elvis Terci Valera and María Sol Brassesco
Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4717-4728
Author(s):
Bradley J. Monk, Thomas J. Herzog and Krishnansu S. Tewari
Novel Immunotherapies for Hematological Malignancies
Journal:
Current Molecular Pharmacology
Volume:
9
Page:
264-271
Author(s):
Monali Vasekar, Syed Rizvi, Xin Liu, Kent E. Vrana and Hong Zheng
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
701-709
Author(s):
Lukas Smolej